Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_25820 | 32 | 0.67 | Mlig455_061208 | Neo: - Age: - |
Mlig455_061208 {REF} {Length: 1262} {Celegans: WBGene00018026, F35A5.4, [Score=48.1, Expect=1e-06]} {RNA1310_123558} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -2.083 | 1.056 | 1.00000 | 1.00000 | |
RegionR2 | 1.989 | 1.056 | 0.89900 | 1.00000 | |
RegionR3 | -0.188 | 1.056 | 1.00000 | 1.00000 | |
RegionR4 | 1.599 | 1.056 | 0.11039 | 0.32856 | |
RegionR5 | 1.536 | 1.056 | 0.13226 | 0.37026 | |
RegionR6 | -0.598 | 1.056 | 1.00000 | 1.00000 | |
RegionR7 | -1.41 | 1.056 | 1.00000 | 1.00000 | |
RegionR8 | -0.845 | 1.056 | 0.99972 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.816 | 1.056 | 0.99983 | 1.00000 | |
RegenerationR2 | -0.374 | 1.056 | 0.59795 | 0.91505 | |
RegenerationR3 | -0.579 | 1.056 | 0.54821 | 0.88273 | |
RegenerationR4 | -1.891 | 1.056 | 0.46823 | 0.85244 | |
RegenerationR5 | -1.332 | 1.056 | 0.64072 | 0.92722 | |
RegenerationR6 | 3.317 | 1.056 | 0.33769 | 0.68387 | |
RegenerationBL | 2.91 | 1.056 | 0.62520 | 0.96750 | |
RegenerationTP | 2.46 | 1.056 | 0.69815 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_25820 | 32 | 0.67 | Mlig455_061208 | Neo: - Age: - |
3 | - | - | 1.000 | 1.000 | 1.000 | - | Mlig455_061208 {REF} {Length: 1262} {Celegans: WBGene00018026, F35A5.4, [Score=48.1, Expect=1e-06]} {RNA1310_123558} | |
2. | MligTC455_30599 | 62 | 1.29 | Mlig455_035018, Mlig455_053448 | Neo: - Age: Up-Down-Up |
CRHR1, LINC02210-CRHR1 | 1.92 | - | - | 0.931 | - | 0.989 | - | Mlig455_035018 {REF} {Length: 707} {Pfam: 7 transmembrane receptor (Secretin family) [PF00002.26, score=19.9]} {Human: ENSG00000263715, LINC02210-CRHR1, LINC02210-CRHR1 readthrough, [Score=66.2, Expect=2e-13]; ENSG00000120088, CRHR1, corticotropin releasing hormone receptor 1, [Score=66.2, Expect=5e-13]; ENSG00000278232, CRHR1, corticotropin releasing hormone receptor 1, [Score=66.2, Expect=5e-13]; ENSG00000276191, CRHR1, corticotropin releasing hormone receptor 1, [Score=66.2, Expect=5e-13]} {Mouse: ENSMUSG00000018634, Crhr1, corticotropin releasing hormone receptor 1, [Score=65.5, Expect=8e-13]} {Dmel: FBgn0260753, Pdfr, Pigment-dispersing factor receptor, [Score=65.1, Expect=7e-13]} {Celegans: WBGene00015735, pdfr-1, Calcitonin receptor-like protein 1, [Score=60.1, Expect=3e-11]} {Smed: dd_Smed_v6_22246_0_1, dd_Smed_v6_22246_0_1, [Score=52.0, Expect=1e-08]} {RNA1310_81830} Mlig455_053448 {REF} {Length: 4522} {Pfam: 7 transmembrane receptor (Secretin family) [PF00002.26, score=21.7]} {Human: ENSG00000120088, CRHR1, corticotropin releasing hormone receptor 1, [Score=67.4, Expect=4e-13]; ENSG00000263715, LINC02210-CRHR1, LINC02210-CRHR1 readthrough, [Score=67.4, Expect=1e-13]; ENSG00000278232, CRHR1, corticotropin releasing hormone receptor 1, [Score=67.4, Expect=4e-13]; ENSG00000276191, CRHR1, corticotropin releasing hormone receptor 1, [Score=67.4, Expect=4e-13]} {Mouse: ENSMUSG00000018634, Crhr1, corticotropin releasing hormone receptor 1, [Score=66.6, Expect=5e-13]} {Dmel: FBgn0260753, Pdfr, Pigment-dispersing factor receptor, [Score=63.9, Expect=3e-12]} {Celegans: WBGene00015735, pdfr-1, Calcitonin receptor-like protein 1, [Score=62.0, Expect=1e-11]} {Smed: dd_Smed_v6_22246_0_1, dd_Smed_v6_22246_0_1, [Score=52.4, Expect=2e-08]} {RNA1509_31473} {RNA1310_51110.1} {RNA815_20842.1} |
3. | MligTC455_39719 | 44 | 0.92 | Mlig455_063602 | Neo: - Age: - |
MPDZ | 1.809 | - | - | 0.958 | - | 0.851 | - | Mlig455_063602 {REF} {Length: 2307} {Pfam: PDZ domain [PF00595.26, score=187.6]; PDZ domain [PF17820.3, score=85.4]; PDZ domain [PF13180.8, score=85.1]} {Human: ENSG00000107186, MPDZ, multiple PDZ domain crumbs cell polarity complex component, [Score=244, Expect=9e-70]} {Mouse: ENSMUSG00000028402, Mpdz, multiple PDZ domain protein, [Score=237, Expect=7e-67]} {Dmel: FBgn0263289, scrib, scribbled, [Score=88.6, Expect=6e-18]} {Celegans: WBGene00003404, mpz-1, Multiple PDZ domain protein, [Score=137, Expect=7e-35]} {Smed: dd_Smed_v6_4520_0_1, dd_Smed_v6_4520_0_1, [Score=147, Expect=2e-37]} {RNA1310_8275.3} {RNA815_16615} |
4. | MligTC455_28430 | 161 | 3.35 | Mlig455_058777, Mlig455_066475 | Neo: - Age: - |
1.769 | - | - | 0.961 | - | 0.808 | - | Mlig455_058777 {REF} {Length: 1822} {RNA1509_18349} {RNA1310_37185} {RNA815_17990} Mlig455_066475 {REF} {Length: 5204} {tRNA: Val(CAC),pseudo, score=36.5} {RNA1509_21400} {RNA1310_576.1} {RNA815_2733.1} |
|
5. | MligTC455_50410 | 31 | 0.64 | Mlig455_020239 | Neo: - Age: - |
GRIA2 | 1.769 | - | - | 0.976 | - | 0.793 | - | Mlig455_020239 {REF} {Length: 2096} {Pfam: Ligand-gated ion channel [PF00060.28, score=192.2]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=127.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=91.1]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=513, Expect=7e-173]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=496, Expect=3e-166]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=494, Expect=8e-167]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=491, Expect=1e-164]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=507, Expect=4e-171]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=497, Expect=4e-167]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=494, Expect=1e-165]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=491, Expect=1e-164]} {Dmel: FBgn0038837, CG3822, [Score=432, Expect=1e-142]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [Score=459, Expect=5e-152]} {Smed: dd_Smed_v6_7562_0_1, dd_Smed_v6_7562_0_1, [Score=528, Expect=2e-179]} {RNA1509_56139} {RNA1310_38868} {RNA815_32684} |
6. | MligTC455_51807 | 28 | 0.59 | Mlig455_046394 | Neo: - Age: - |
GPSM2 | 1.763 | - | - | 0.959 | - | 0.804 | - | Mlig455_046394 {REF} {Length: 3388} {Pfam: Tetratricopeptide repeat [PF13424.8, score=114.4]; Tetratricopeptide repeat [PF13176.8, score=96.0]; Tetratricopeptide repeat [PF00515.30, score=94.3]; GoLoco motif [PF02188.19, score=85.6]; Tetratricopeptide repeat [PF07719.19, score=55.0]; Tetratricopeptide repeat [PF13181.8, score=42.2]; Tetratricopeptide repeat [PF13374.8, score=32.8]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=20.1]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [RH, Score=542, Expect=0.0]} {Mouse: ENSMUSG00000027883, Gpsm2, G-protein signalling modulator 2 (AGS3-like, C. elegans), [RH, Score=532, Expect=1e-180]; ENSMUSG00000026930, Gpsm1, G-protein signalling modulator 1 (AGS3-like, C. elegans), [RH, Score=511, Expect=1e-172]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=530, Expect=2e-180]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [RH, Score=266, Expect=7e-80]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=477, Expect=1e-159]} {RNA1310_18538} {RNA815_41322} |
7. | MligTC455_22356 | 28 | 0.57 | Mlig455_009532 | Neo: - Age: - Region-enriched R5: 4.548/0.03532 |
GALR2 | 1.757 | - | - | 0.964 | - | 0.793 | - | Mlig455_009532 {REF} {Length: 3801} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=72.4]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=50.8, Expect=6e-06]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=52.4, Expect=1e-06]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=50.1, Expect=3e-06]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [Score=126, Expect=3e-31]} {RNA1310_79397} {RNA815_39017} |
8. | MligTC455_44159 | 80 | 1.67 | Mlig455_019040, Mlig455_055663 | Neo: - Age: Down-Up-Up |
ADRB1, GALR3 | 1.753 | - | - | 0.965 | - | 0.788 | - | Mlig455_019040 {REF} {Length: 1804} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=78.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=31.3]} {Human: ENSG00000043591, ADRB1, adrenoceptor beta 1, [Score=52.8, Expect=5e-07]} {Mouse: ENSMUSG00000034987, Hrh2, histamine receptor H2, [Score=47.8, Expect=1e-05]} {Dmel: FBgn0038874, ETHR, [Score=49.3, Expect=3e-06]} {Celegans: WBGene00017661, frpr-6, FMRFamide Peptide Receptor family, [Score=54.3, Expect=5e-08]} {Smed: dd_Smed_v6_19933_0_1, dd_Smed_v6_19933_0_1, [RH, Score=124, Expect=9e-33]} {RNA1310_47955} {RNA815_45615} Mlig455_055663 {REF} {Length: 1667} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=47.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.2]} {Human: ENSG00000128310, GALR3, galanin receptor 3, [Score=50.1, Expect=2e-06]} {Smed: dd_Smed_v6_14726_0_1, dd_Smed_v6_14726_0_1, [Score=103, Expect=6e-25]} {RNA1310_86586} {RNA815_45615} |
9. | MligTC455_51189 | 50 | 1.04 | Mlig455_009762 | Neo: - |
ETV1 | 1.752 | - | - | 0.778 | - | 0.974 | - | Mlig455_009762 {REF} {Length: 2915} {Pfam: Ets-domain [PF00178.24, score=116.1]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=19.9]} {Human: ENSG00000006468, ETV1, ETS variant 1, [RH, Score=196, Expect=6e-55]; ENSG00000244405, ETV5, ETS variant 5, [RH, Score=195, Expect=3e-54]; ENSG00000175832, ETV4, ETS variant 4, [RH, Score=193, Expect=5e-54]} {Mouse: ENSMUSG00000013089, Etv5, ets variant 5, [RH, Score=196, Expect=1e-54]; ENSMUSG00000004151, Etv1, ets variant 1, [RH, Score=195, Expect=5e-55]; ENSMUSG00000017724, Etv4, ets variant 4, [RH, Score=193, Expect=6e-54]} {Dmel: FBgn0039225, Ets96B, [RH, Score=186, Expect=3e-50]} {Celegans: WBGene00016600, ets-5, ETS class transcription factor, [Score=121, Expect=2e-31]} {Smed: dd_Smed_v6_14712_0_1, dd_Smed_v6_14712_0_1, [RH, Score=169, Expect=7e-46]} {RNA1310_33762} {RNA815_60843} |
10. | MligTC455_43212 | 25 | 0.51 | Mlig455_030578 | Neo: - Age: - |
ZNF16 | 1.727 | - | - | 0.975 | - | 0.752 | - | Mlig455_030578 {REF} {Length: 1942} {TRANSSPLICED} {Pfam: C2H2-type zinc finger [PF13894.8, score=55.4]; Zinc finger, C2H2 type [PF00096.28, score=51.0]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=38.5]; Zinc-finger of C2H2 type [PF12874.9, score=34.0]; C2H2 type zinc-finger (2 copies) [PF12756.9, score=25.9]; Zinc-fingers and homeoboxes C2H2 finger domain [PF18387.3, score=20.8]; Zinc finger C2H2-type, 3 repeats [PF18868.3, score=19.4]} {Human: ENSG00000170631, ZNF16, zinc finger protein 16, [Score=84.7, Expect=6e-17]; ENSG00000178175, ZNF366, zinc finger protein 366, [Score=82.0, Expect=4e-16]; ENSG00000213973, ZNF99, zinc finger protein 99, [Score=81.6, Expect=7e-16]; ENSG00000196350, ZNF729, zinc finger protein 729, [Score=80.5, Expect=2e-15]; ENSG00000180787, ZFP3, ZFP3 zinc finger protein, [Score=80.5, Expect=9e-16]} {Mouse: ENSMUSG00000059897, Zfp930, zinc finger protein 930, [Score=83.2, Expect=7e-17]; ENSMUSG00000050919, Zfp366, zinc finger protein 366, [Score=80.1, Expect=1e-15]} {Dmel: FBgn0038550, CG17801, [Score=68.9, Expect=2e-12]} {Celegans: WBGene00012639, fezf-1, FEZ Family zinc finger protein, [Score=52.4, Expect=1e-07]} {Smed: dd_Smed_v6_11840_0_1, dd_Smed_v6_11840_0_1, [Score=57.8, Expect=4e-09]} {RNA1509_14767, RNA1509_19735} {RNA1310_5349, RNA1509_19735} {RNA1509_19735, RNA815_28876} |
11. | MligTC455_42514 | 28 | 0.59 | Mlig455_027746 | Neo: - Age: Up-Down-Down |
KCNC2 | 1.722 | - | - | 0.989 | - | 0.733 | - | Mlig455_027746 {REF} {Length: 2596} {Pfam: Ion transport protein [PF00520.33, score=123.8]; BTB/POZ domain [PF02214.24, score=86.8]; Ion channel [PF07885.18, score=37.1]} {Human: ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=284, Expect=2e-86]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=279, Expect=3e-85]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=270, Expect=2e-81]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=279, Expect=3e-85]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=270, Expect=2e-81]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=280, Expect=7e-87]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=303, Expect=3e-94]} {Smed: dd_Smed_v6_13250_0_1, dd_Smed_v6_13250_0_1, [Score=286, Expect=3e-88]} {RNA1509_33421} {RNA1310_15684} {RNA815_16308} |
12. | MligTC455_41035 | 366 | 7.62 | Mlig455_000866 | Neo: - Age: logFC(26M/2M)=-0.773 Region-specific R2: 5.029 Region-enriched R2: 4.768/0.00000 |
1.702 | - | - | 0.750 | - | 0.952 | - | Mlig455_000866 {REF} {Length: 1126} {Pfam: Pancreatic hormone peptide [PF00159.20, score=41.6]} {RNA1509_27581} {RNA1310_74103, RNA1509_27581} {RNA1509_27581, RNA815_38377} | |
13. | MligTC455_29108 | 43 | 0.9 | Mlig455_052031 | Neo: - Age: logFC(26M/2M)=-0.764 |
1.7 | - | - | 0.964 | - | 0.736 | - | Mlig455_052031 {REF} {Length: 3111} {NoTransDecoderORF} {RNA1310_19531.2} {RNA815_10097} | |
14. | MligTC455_40649 | 24 | 0.49 | Mlig455_066232 | Neo: - Age: - |
1.695 | - | - | 0.971 | - | 0.724 | - | Mlig455_066232 {REF} {Length: 2453} {RNA1310_42980.1} {RNA815_47590} | |
15. | MligTC455_40199 | 64 | 1.33 | Mlig455_026444, Mlig455_026477 | Neo: - Age: - |
ASIC4 | 1.686 | - | - | 0.961 | - | 0.725 | - | Mlig455_026444 {REF} {Length: 2570} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=204.0]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=57.4, Expect=7e-08]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=53.9, Expect=5e-07]; ENSMUSG00000038276, Asic3, acid-sensing (proton-gated) ion channel 3, [Score=52.4, Expect=1e-06]} {Celegans: WBGene00003174, mec-10, Degenerin mec-10, [Score=69.7, Expect=5e-12]} {Smed: dd_Smed_v6_12878_0_1, dd_Smed_v6_12878_0_1, [Score=119, Expect=6e-28]} {RNA1310_21223} {RNA815_27174} Mlig455_026477 {REF} {Length: 2402} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=160.5]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=57.0, Expect=8e-08]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=53.9, Expect=5e-07]} {Celegans: WBGene00003174, mec-10, Degenerin mec-10, [Score=69.3, Expect=5e-12]} {Smed: dd_Smed_v6_12878_0_1, dd_Smed_v6_12878_0_1, [Score=93.6, Expect=9e-20]} {RNA1310_21223} {RNA815_27174} |
16. | MligTC455_20200 | 47 | 0.97 | Mlig455_021962 | Neo: - Age: - |
KCNMA1 | 1.684 | - | - | 0.953 | - | 0.731 | - | Mlig455_021962 {REF} {Length: 3749} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=76.1]; Ion channel [PF07885.18, score=61.3]; Ion transport protein [PF00520.33, score=34.6]; Ligand-gated ion channel [PF00060.28, score=23.9]} {Human: ENSG00000156113, KCNMA1, potassium calcium-activated channel subfamily M alpha 1, [Score=634, Expect=0.0]} {Mouse: ENSMUSG00000063142, Kcnma1, potassium large conductance calcium-activated channel, subfamily M, alpha member 1, [Score=628, Expect=0.0]} {Dmel: FBgn0003429, slo, slowpoke, [Score=449, Expect=8e-139]} {Celegans: WBGene00004830, slo-1, Calcium-activated potassium channel slo-1, [Score=444, Expect=2e-137]} {Smed: dd_Smed_v6_5509_0_1, dd_Smed_v6_5509_0_1, [Score=610, Expect=0.0]} {RNA1310_43306.1} {RNA815_38585} |
17. | MligTC455_53333 | 44 | 0.91 | Mlig455_019019, Mlig455_055684 | Neo: - Age: Up-Down-Up Region-enriched R4: 4.725/0.03950 |
CHRNA7 | 0.99 | - | - | 0.990 | - | - | - | Mlig455_019019 {REF} {Length: 2615} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=93.9]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=210, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=207, Expect=8e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=206, Expect=3e-58]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=1e-59]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=205, Expect=3e-58]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=221, Expect=3e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=7e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=426, Expect=5e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} Mlig455_055684 {REF} {Length: 2604} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=94.7]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=211, Expect=9e-60]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=209, Expect=3e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=207, Expect=7e-59]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=9e-60]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=204, Expect=1e-57]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=222, Expect=1e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=6e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=427, Expect=3e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} |
18. | MligTC455_36703 | 21 | 0.43 | Mlig455_032688 | Neo: - Age: - |
0.984 | - | - | 0.984 | - | - | - | Mlig455_032688 {REF} {Length: 7822} {RNA1509_59817} {RNA1310_14959.1} {RNA815_22311} | |
19. | MligTC455_07428 | 12 | 0.25 | Mlig455_055209 | Neo: - Age: - |
0.979 | - | - | 0.979 | - | - | - | Mlig455_055209 {REF} {Length: 759} {RNA1310_50531} {RNA815_29422} | |
20. | MligTC455_27066 | 95 | 1.99 | Mlig455_008802 | Neo: - Age: - |
0.974 | - | - | 0.974 | - | - | - | Mlig455_008802 {REF} {Length: 1551} {NoTransDecoderORF} {RNA1509_44223} {RNA1310_54802} {RNA815_64986} | |
21. | MligTC455_40438 | 58 | 1.2 | Mlig455_009382, Mlig455_009671, Mlig455_036938 | Neo: - Age: - |
0.974 | - | - | - | - | 0.974 | - | Mlig455_009382 {REF} {Length: 2226} {RNA1310_31887.1} {RNA815_44554} Mlig455_009671 {REF} {Length: 2041} {RNA1310_31887.1} {RNA815_44554} Mlig455_036938 {REF} {Length: 2602} {RNA1310_31887.1} {RNA815_37367.1} |
|
22. | MligTC455_37452 | 116 | 2.42 | Mlig455_046278 | Neo: - Age: - |
0.972 | - | - | 0.972 | - | - | - | Mlig455_046278 {REF} {Length: 4416} {Pfam: Antitoxin VbhA [PF18495.3, score=20.4]} {RNA1509_26805, RNA1509_49672} {RNA1310_2903.3, RNA1509_49672} {RNA1509_49672, RNA815_6251} | |
23. | MligTC455_12958 | 55 | 1.15 | Mlig455_055683 | Neo: - Age: - |
0.97 | - | - | 0.970 | - | - | - | Mlig455_055683 {REF} {Length: 1376} | |
24. | MligTC455_25445 | 12 | 0.24 | Mlig455_021534 | Neo: - Age: Up-Down-Up |
CACNA1D | 0.97 | - | - | 0.970 | - | - | - | Mlig455_021534 {REF} {Length: 4880} {Pfam: Ion transport protein [PF00520.33, score=359.2]; Voltage gated calcium channel IQ domain [PF08763.13, score=102.5]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=91.9]} {Human: ENSG00000157388, CACNA1D, calcium voltage-gated channel subunit alpha1 D, [Score=971, Expect=0.0]; ENSG00000081248, CACNA1S, calcium voltage-gated channel subunit alpha1 S, [Score=957, Expect=0.0]; ENSG00000151067, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [Score=944, Expect=0.0]; ENSG00000285479, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [Score=944, Expect=0.0]} {Mouse: ENSMUSG00000015968, Cacna1d, calcium channel, voltage-dependent, L type, alpha 1D subunit, [Score=971, Expect=0.0]; ENSMUSG00000051331, Cacna1c, calcium channel, voltage-dependent, L type, alpha 1C subunit, [Score=959, Expect=0.0]; ENSMUSG00000026407, Cacna1s, calcium channel, voltage-dependent, L type, alpha 1S subunit, [Score=958, Expect=0.0]} {Dmel: FBgn0001991, Ca-alpha1D, Ca[2+]-channel protein alpha[[1]] subunit D, [Score=989, Expect=0.0]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=1053, Expect=0.0]} {Smed: dd_Smed_v6_8899_0_17, dd_Smed_v6_8899_0_17, [Score=1104, Expect=0.0]} {RNA1509_48072} {RNA1310_376.1} {RNA815_1126.1} |
25. | MligTC455_10413 | 12 | 0.24 | Mlig455_053242, Mlig455_066367 | Neo: - Age: - |
LHFPL6 | 0.968 | - | - | 0.968 | - | - | - | Mlig455_053242 {REF} {Length: 1343} {Pfam: Lipoma HMGIC fusion partner-like protein [PF10242.11, score=114.6]; PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=21.4]; Lipid II flippase MurJ [PF03023.16, score=20.7]} {Human: ENSG00000183722, LHFPL6, LHFPL tetraspan subfamily member 6, [RH, Score=81.6, Expect=2e-17]} {Mouse: ENSMUSG00000048332, Lhfp, lipoma HMGIC fusion partner, [RH, Score=79.7, Expect=8e-17]} {Smed: dd_Smed_v6_9373_0_1, dd_Smed_v6_9373_0_1, [RH, Score=181, Expect=4e-53]} {RNA1310_36894} {RNA815_56428} Mlig455_066367 {REF} {Length: 1706} {Pfam: Lipoma HMGIC fusion partner-like protein [PF10242.11, score=114.6]; PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=21.4]; Lipid II flippase MurJ [PF03023.16, score=20.7]} {Human: ENSG00000183722, LHFPL6, LHFPL tetraspan subfamily member 6, [RH, Score=81.6, Expect=2e-17]} {Mouse: ENSMUSG00000048332, Lhfp, lipoma HMGIC fusion partner, [RH, Score=79.7, Expect=8e-17]} {Smed: dd_Smed_v6_9373_0_1, dd_Smed_v6_9373_0_1, [RH, Score=181, Expect=4e-53]} {RNA1509_28410} {RNA1310_83173.1} {RNA815_56428} |
26. | MligTC455_39455 | 42 | 0.87 | Mlig455_036460 | Neo: - Age: - |
0.968 | - | - | 0.968 | - | - | - | Mlig455_036460 {REF} {Length: 1044} {NoTransDecoderORF} {RNA1509_44223} {RNA1310_54802} {RNA815_64986} | |
27. | MligTC455_01014 | 50 | 1.04 | Mlig455_061332 | Neo: - Age: - |
0.967 | - | - | 0.967 | - | - | - | Mlig455_061332 {REF} {Length: 923} {RNA1310_87489} | |
28. | MligTC455_03555 | 28 | 0.59 | Mlig455_009266 | Neo: - Age: Up-Up-Down |
0.967 | - | - | 0.967 | - | - | - | Mlig455_009266 {REF} {Length: 1235} {NoTransDecoderORF} {RNA1509_42100} {RNA1310_56786} {RNA815_61979} | |
29. | MligTC455_13788 | 51 | 1.05 | Mlig455_007698 | Neo: - Age: - |
0.966 | - | - | 0.966 | - | - | - | Mlig455_007698 {REF} {Length: 1318} {RNA1310_34364} | |
30. | MligTC455_49922 | 36 | 0.76 | Mlig455_049338 | Neo: - Age: Down-Down-Up Region-enriched R2: 7.622/0.00496 |
0.966 | - | - | 0.966 | - | - | - | Mlig455_049338 {REF} {Length: 971} {RNA1310_37449} {RNA815_3585} | |
31. | MligTC455_33449 | 53 | 1.11 | Mlig455_048658, Mlig455_063410 | Neo: - Age: - |
0.964 | - | - | 0.964 | - | - | - | Mlig455_048658 {REF} {Length: 1769} {Mouse: ENSMUSG00000020396, Nefh, neurofilament, heavy polypeptide, [Score=86.3, Expect=5e-17]} {RNA1509_51537} {RNA1310_24973} {RNA815_7432} Mlig455_063410 {REF} {Length: 2520} {Pfam: Sporozoite P67 surface antigen [PF05642.13, score=19.6]} {RNA1509_51537} {RNA1310_24973} {RNA815_7432} |
|
32. | MligTC455_50304 | 17 | 0.35 | Mlig455_067422 | Neo: - Age: - |
0.964 | - | - | 0.964 | - | - | - | Mlig455_067422 {REF} {Length: 751} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_51606} {RNA1310_82384} {RNA815_44872} | |
33. | MligTC455_25242 | 55 | 1.15 | Mlig455_046799, Mlig455_063518 | Neo: - Age: - Region-enriched R2: 5.810/0.00185 |
DOC2B, RPH3A | 0.963 | - | - | - | - | 0.963 | - | Mlig455_046799 {REF} {Length: 1832} {Pfam: C2 domain [PF00168.32, score=147.1]} {Human: ENSG00000272636, DOC2B, double C2 domain beta, [Score=243, Expect=3e-76]; ENSG00000272670, DOC2B, double C2 domain beta, [Score=243, Expect=3e-76]; ENSG00000089169, RPH3A, rabphilin 3A, [Score=237, Expect=3e-71]; ENSG00000149927, DOC2A, double C2 domain alpha, [Score=234, Expect=1e-72]} {Mouse: ENSMUSG00000020848, Doc2b, double C2, beta, [Score=243, Expect=3e-76]; ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=239, Expect=1e-74]; ENSMUSG00000029608, Rph3a, rabphilin 3A, [Score=237, Expect=4e-71]} {Dmel: FBgn0030230, Rph, Rabphilin, [RH, Score=188, Expect=2e-55]} {Celegans: WBGene00004316, rbf-1, Rabphilin-1, [Score=216, Expect=4e-62]} {Smed: dd_Smed_v6_12977_0_1, dd_Smed_v6_12977_0_1, [Score=239, Expect=5e-73]} {RNA1310_26201} {RNA815_12702} Mlig455_063518 {REF} {Length: 2724} {Pfam: C2 domain [PF00168.32, score=147.7]} {Human: ENSG00000089169, RPH3A, rabphilin 3A, [RH, Score=240, Expect=2e-72]} {Mouse: ENSMUSG00000029608, Rph3a, rabphilin 3A, [RH, Score=240, Expect=2e-72]} {Dmel: FBgn0030230, Rph, Rabphilin, [RH, Score=191, Expect=1e-54]} {Celegans: WBGene00004316, rbf-1, Rabphilin-1, [Score=219, Expect=4e-63]} {Smed: dd_Smed_v6_12977_0_2, dd_Smed_v6_12977_0_2, [Score=241, Expect=1e-73]} {RNA1310_26201} {RNA815_12702} |
34. | MligTC455_51399 | 52 | 1.09 | Mlig455_051021 | Neo: - Age: Up-Down-Down |
KCNT1 | 0.963 | - | - | - | - | 0.963 | - | Mlig455_051021 {REF} {Length: 4250} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=92.3]; Ion channel [PF07885.18, score=44.0]} {Human: ENSG00000107147, KCNT1, potassium sodium-activated channel subfamily T member 1, [Score=901, Expect=0.0]; ENSG00000162687, KCNT2, potassium sodium-activated channel subfamily T member 2, [Score=862, Expect=0.0]} {Mouse: ENSMUSG00000058740, Kcnt1, potassium channel, subfamily T, member 1, [Score=870, Expect=0.0]; ENSMUSG00000052726, Kcnt2, potassium channel, subfamily T, member 2, [Score=870, Expect=0.0]} {Dmel: FBgn0261698, SLO2, slowpoke 2, [RH, Score=818, Expect=0.0]} {Celegans: WBGene00004831, slo-2, SLO-2 potassium channel; SLOwpoke potassium channel family, [Score=666, Expect=0.0]} {Smed: dd_Smed_v6_9739_0_1, dd_Smed_v6_9739_0_1, [Score=1093, Expect=0.0]} {RNA1509_10851} {RNA1310_10826.1} {RNA815_3987} |
35. | MligTC455_53813 | 46 | 0.96 | Mlig455_038036 | Neo: - Age: Down-Down-Up |
0.963 | - | - | 0.963 | - | - | - | Mlig455_038036 {REF} {Length: 1511} {Smed: dd_Smed_v6_12148_0_3, dd_Smed_v6_12148_0_3, [Score=70.5, Expect=9e-14]} {RNA1310_21968} {RNA815_20437} | |
36. | MligTC455_47174 | 224 | 4.66 | Mlig455_060951 | Neo: - Age: - Region-enriched R6: 6.675/0.00000 |
0.962 | - | - | - | 0.962 | - | - | Mlig455_060951 {REF} {Length: 806} {Pfam: Kazal-type serine protease inhibitor domain [PF07648.17, score=40.9]; Kazal-type serine protease inhibitor domain [PF00050.23, score=35.0]} {RNA1509_43736} {RNA1310_34269} {RNA815_28780} | |
37. | MligTC455_10729 | 44 | 0.93 | Mlig455_011434 | Neo: - Age: - |
0.96 | - | - | 0.960 | - | - | - | Mlig455_011434 {REF} {Length: 429} {NoTransDecoderORF} {RNA1509_36541} {RNA1310_37624} {RNA815_20457.1} | |
38. | MligTC455_11804 | 40 | 0.84 | Mlig455_049994, Mlig455_050022 | Neo: - Age: Up-Down-Up |
0.96 | - | - | 0.960 | - | - | - | Mlig455_049994 {REF} {Length: 2541} {TRANSSPLICED} {RNA1310_33428} {RNA815_20155} Mlig455_050022 {REF} {Length: 1815} {TRANSSPLICED} {RNA1310_33428} {RNA815_20155} |
|
39. | MligTC455_50219 | 35 | 0.73 | Mlig455_006785 | Neo: - Age: - |
0.96 | - | - | 0.960 | - | - | - | Mlig455_006785 {REF} {Length: 787} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=67.2]} {Smed: dd_Smed_v6_17245_0_1, dd_Smed_v6_17245_0_1, [Score=55.5, Expect=9e-10]} {RNA1509_47645} {RNA1310_28371} {RNA815_4577.1} | |
40. | MligTC455_24636 | 196 | 4.07 | Mlig455_004476, Mlig455_004503, Mlig455_037369 | Neo: - Age: - |
SCRT1, SCRT2 | 0.959 | - | - | - | 0.959 | - | - | Mlig455_004476 {REF} {Length: 1110} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=82.8]; C2H2-type zinc finger [PF13894.8, score=64.3]; Zinc-finger double domain [PF13465.8, score=54.8]; C2H2-type zinc finger [PF13912.8, score=37.0]; zinc-finger C2H2-type [PF16622.7, score=31.7]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=26.9]; C2HE / C2H2 / C2HC zinc-binding finger [PF16278.7, score=26.2]; Zinc-finger of C2H2 type [PF12874.9, score=19.1]} {Human: ENSG00000215397, SCRT2, scratch family transcriptional repressor 2, [Score=222, Expect=2e-70]; ENSG00000284923, SCRT1, scratch family transcriptional repressor 1, [Score=221, Expect=1e-69]; ENSG00000261678, SCRT1, scratch family transcriptional repressor 1, [Score=221, Expect=1e-69]} {Mouse: ENSMUSG00000048385, Scrt1, scratch family zinc finger 1, [Score=228, Expect=3e-72]; ENSMUSG00000060257, Scrt2, scratch family zinc finger 2, [Score=222, Expect=1e-70]} {Dmel: FBgn0004880, scrt, scratch, [Score=256, Expect=5e-80]} {Celegans: WBGene00000468, ces-1, CES-1; CEll death Specification, [RH, Score=211, Expect=3e-67]} {Smed: dd_Smed_v6_18952_0_1, dd_Smed_v6_18952_0_1, [Score=248, Expect=3e-80]} {RNA1310_21478.1} Mlig455_004503 {REF} {Length: 1109} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=82.8]; C2H2-type zinc finger [PF13894.8, score=64.3]; Zinc-finger double domain [PF13465.8, score=54.6]; C2H2-type zinc finger [PF13912.8, score=37.0]; zinc-finger C2H2-type [PF16622.7, score=31.7]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=26.9]; C2HE / C2H2 / C2HC zinc-binding finger [PF16278.7, score=26.6]; zinc-ribbon family [PF17032.7, score=19.6]; Zinc-finger of C2H2 type [PF12874.9, score=19.1]} {Human: ENSG00000215397, SCRT2, scratch family transcriptional repressor 2, [Score=221, Expect=3e-70]; ENSG00000261678, SCRT1, scratch family transcriptional repressor 1, [Score=221, Expect=1e-69]; ENSG00000284923, SCRT1, scratch family transcriptional repressor 1, [Score=221, Expect=1e-69]} {Mouse: ENSMUSG00000048385, Scrt1, scratch family zinc finger 1, [Score=228, Expect=2e-72]; ENSMUSG00000060257, Scrt2, scratch family zinc finger 2, [Score=222, Expect=1e-70]} {Dmel: FBgn0004880, scrt, scratch, [Score=254, Expect=2e-79]} {Celegans: WBGene00000468, ces-1, CES-1; CEll death Specification, [RH, Score=211, Expect=3e-67]} {Smed: dd_Smed_v6_18952_0_1, dd_Smed_v6_18952_0_1, [Score=248, Expect=2e-80]} {RNA1310_21478.1} Mlig455_037369 {REF} {Length: 1110} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=83.3]; C2H2-type zinc finger [PF13894.8, score=64.1]; Zinc-finger double domain [PF13465.8, score=54.0]; C2H2-type zinc finger [PF13912.8, score=37.0]; zinc-finger C2H2-type [PF16622.7, score=32.5]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=26.0]; C2HE / C2H2 / C2HC zinc-binding finger [PF16278.7, score=25.2]; Zinc-finger of C2H2 type [PF12874.9, score=20.6]; zinc-ribbon family [PF17032.7, score=19.4]} {Human: ENSG00000284923, SCRT1, scratch family transcriptional repressor 1, [Score=220, Expect=4e-69]; ENSG00000215397, SCRT2, scratch family transcriptional repressor 2, [Score=220, Expect=1e-69]; ENSG00000261678, SCRT1, scratch family transcriptional repressor 1, [Score=220, Expect=4e-69]} {Mouse: ENSMUSG00000048385, Scrt1, scratch family zinc finger 1, [Score=226, Expect=8e-72]; ENSMUSG00000060257, Scrt2, scratch family zinc finger 2, [Score=221, Expect=4e-70]} {Dmel: FBgn0004880, scrt, scratch, [Score=253, Expect=5e-79]} {Celegans: WBGene00000468, ces-1, CES-1; CEll death Specification, [RH, Score=211, Expect=7e-67]} {Smed: dd_Smed_v6_18952_0_1, dd_Smed_v6_18952_0_1, [Score=246, Expect=2e-79]} {RNA1310_21478.1} |
41. | MligTC455_28723 | 57 | 1.19 | Mlig455_038771 | Neo: - Age: - |
0.959 | - | - | 0.959 | - | - | - | Mlig455_038771 {REF} {Length: 3385} {NoTransDecoderORF} {RNA1509_2485} {RNA1310_64926} {RNA815_131.1} | |
42. | MligTC455_29096 | 98 | 2.03 | Mlig455_065347 | Neo: - Age: logFC(26M/2M)=2.647 |
0.957 | - | - | 0.957 | - | - | - | Mlig455_065347 {REF} {Length: 4150} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=61.9]} {Smed: dd_Smed_v6_13734_0_20, dd_Smed_v6_13734_0_20, [Score=49.3, Expect=2e-06]} {RNA1509_13072} {RNA1310_4523} {RNA815_1327.1} | |
43. | MligTC455_19187 | 156 | 3.26 | Mlig455_018418 | Neo: - Age: - Region-enriched R2: 2.105/0.03594 |
NRXN1 | 0.956 | - | - | 0.956 | - | - | - | Mlig455_018418 {REF} {Length: 6075} {Pfam: Laminin G domain [PF02210.26, score=290.6]; Laminin G domain [PF00054.25, score=213.6]; Syndecan domain [PF01034.22, score=25.6]; EGF-like domain [PF00008.29, score=22.7]} {Human: ENSG00000179915, NRXN1, neurexin 1, [RH, Score=396, Expect=2e-114]} {Mouse: ENSMUSG00000024109, Nrxn1, neurexin I, [Score=408, Expect=3e-119]} {Dmel: FBgn0038975, Nrx-1, Neurexin 1, [Score=315, Expect=2e-87]} {Celegans: WBGene00007799, nrx-1, NRX-1 beta isoform; NeuReXin related, [Score=119, Expect=9e-27]} {Smed: dd_Smed_v6_13697_0_1, dd_Smed_v6_13697_0_1, [RH, Score=429, Expect=2e-128]} {RNA1509_34878} {RNA1310_1222.1} {RNA815_16735} |
44. | MligTC455_51760 | 18 | 0.38 | Mlig455_051796 | Neo: - Age: - |
CNBD2 | 0.955 | - | - | 0.955 | - | - | - | Mlig455_051796 {REF} {Length: 2614} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=74.7]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=67.4, Expect=2e-11]; ENSG00000185532, PRKG1, protein kinase cGMP-dependent 1, [Score=64.3, Expect=4e-10]} {Mouse: ENSMUSG00000052920, Prkg1, protein kinase, cGMP-dependent, type I, [Score=64.7, Expect=2e-10]; ENSMUSG00000038085, Cnbd2, cyclic nucleotide binding domain containing 2, [Score=63.9, Expect=2e-10]} {Dmel: FBgn0259243, Pka-R1, Protein kinase, cAMP-dependent, regulatory subunit type 1, [Score=57.4, Expect=1e-08]} {Celegans: WBGene00015650, pkg-2, Protein Kinase, cGMP-dependent, [Score=61.2, Expect=1e-09]} {Smed: dd_Smed_v6_17565_0_1, dd_Smed_v6_17565_0_1, [Score=174, Expect=1e-46]} {RNA1310_33768} {RNA815_47620} |
45. | MligTC455_11168 | 10 | 0.21 | Mlig455_015184 | Neo: - Age: - |
0.952 | - | - | 0.952 | - | - | - | Mlig455_015184 {REF} {Length: 1552} {NoTransDecoderORF} {RNA1509_44393} {RNA1310_60529.2} {RNA815_62333} | |
46. | MligTC455_37195 | 68 | 1.41 | Mlig455_033638, Mlig455_033665 | Neo: - Age: Up-Down-Down |
ASIC1 | 0.952 | - | - | 0.952 | - | - | - | Mlig455_033638 {REF} {Length: 3007} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=199.6]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=60.8, Expect=4e-09]} {Mouse: ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=55.8, Expect=1e-07]} {Celegans: WBGene00006832, unc-105, Degenerin-like protein unc-105, [Score=67.8, Expect=1e-11]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [RH, Score=483, Expect=5e-165]} {RNA1509_46829} {RNA1310_13649} {RNA815_15065} Mlig455_033665 {REF} {Length: 4082} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=199.8]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=62.0, Expect=2e-09]} {Mouse: ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=56.6, Expect=6e-08]} {Celegans: WBGene00006832, unc-105, Degenerin-like protein unc-105, [Score=68.6, Expect=9e-12]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [RH, Score=483, Expect=8e-165]} {RNA1509_46829} {RNA1310_13649, RNA1509_46829} {RNA1509_46829, RNA815_15065} |
47. | MligTC455_53637 | 3377 | 70.36 | Mlig455_026738, Mlig455_051749 | Neo: - Age: Down-Down-Up Region-enriched R8: 2.667/0.00000 Regeneration-downregulated BL: -2.506 Regeneration-depleted BL: -2.506 |
0.951 | - | - | - | - | 0.951 | - | Mlig455_026738 {REF} {Length: 1503} {RNA1509_14499} {RNA1310_49321, RNA1509_14499} {RNA1509_14499, RNA815_24877} Mlig455_051749 {REF} {Length: 639} {RNA1509_14499} {RNA1310_49321} {RNA815_24877} |
|
48. | MligTC455_13843 | 106 | 2.21 | Mlig455_002736, Mlig455_063352 | Neo: - Age: - |
0.95 | - | - | 0.950 | - | - | - | Mlig455_002736 {REF} {Length: 2644} {Mouse: ENSMUSG00000050463, Krt78, keratin 78, [Score=53.9, Expect=7e-09]} Mlig455_063352 {REF} {Length: 1108} {Mouse: ENSMUSG00000050463, Krt78, keratin 78, [Score=68.6, Expect=1e-13]} |
|
49. | MligTC455_30572 | 88 | 1.82 | Mlig455_009374, Mlig455_026650 | Neo: - Age: Down-Down-Down |
NYNRIN | 0.95 | - | - | 0.950 | - | - | - | Mlig455_009374 {REF} {Length: 592} {Pfam: RNase H-like domain found in reverse transcriptase [PF17917.3, score=104.1]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=103.6]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=57.8]; Integrase zinc binding domain [PF17921.3, score=56.9]; Integrase core domain [PF00665.28, score=46.3]; gag-polyprotein putative aspartyl protease [PF13975.8, score=22.7]} {Human: ENSG00000205978, NYNRIN, NYN domain and retroviral integrase containing, [Score=71.2, Expect=8e-12]} {Mouse: ENSMUSG00000075592, Nynrin, NYN domain and retroviral integrase containing, [Score=72.0, Expect=3e-12]} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=262, Expect=3e-73]} {RNA1509_8906} {RNA1310_1712.2} {RNA815_474.1} Mlig455_026650 {REF} {Length: 3906} {Pfam: RNase H-like domain found in reverse transcriptase [PF17917.3, score=104.1]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=103.6]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=57.8]; Integrase zinc binding domain [PF17921.3, score=56.9]; Integrase core domain [PF00665.28, score=46.3]; gag-polyprotein putative aspartyl protease [PF13975.8, score=22.7]} {Human: ENSG00000205978, NYNRIN, NYN domain and retroviral integrase containing, [Score=71.2, Expect=8e-12]} {Mouse: ENSMUSG00000075592, Nynrin, NYN domain and retroviral integrase containing, [Score=72.0, Expect=3e-12]} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=262, Expect=3e-73]} {RNA1509_8906} {RNA1310_1712.3} {RNA815_474.1} |